Atara Biotherapeutics, Inc. (ATRA) income statement
ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.34−0.43 (-6.35%)
Close on Nov 19, 2026Market cap $63.64MP/E –Yield –
Atara Biotherapeutics, Inc. financial ratios
See a number that looks wrong?